- In July 2023, Alkem’s Laboratories expanded its reach into the field of ophthalmology by launching a comprehensive range of high-quality, affordable eye care products. This strategic move highlights Alkem's commitment to innovation and its dedication to addressing the diverse needs of patients with various eye conditions. By offering reasonably priced eye care solutions, Alkem aims to improve access to quality eye care and enhance the overall well-being of patients. This new venture is part of Alkem's broader mission to provide innovative and patient-centric healthcare solutions, making a positive impact on eye health globally
- In July 2023, PeriVision successfully closed its first seed funding round, marking a significant milestone in revolutionizing eye diagnostics and care. The company leverages cutting-edge technologies such as artificial intelligence, virtual reality, and cloud computation to transform traditional eye testing methods. PeriVision's innovative portfolio includes virtual eye exams conducted using commercial VR headsets. This approach enables physicians to optimize eye examinations, ensure quality control, and gain valuable insights for making informed clinical decisions. The successful funding round is a testament to PeiVision's potential to redefine eye care and diagnostics through technological advancements
- In July 2023, Perivision achieved a significant milestone by successfully closing its first round of seed funding. This financial boost is set to transform the way eye diagnostics are conducted. PeriVision is harnessing the power of cutting-edge technologies like artificial intelligence (AI), virtual reality (VR), and cloud computing to innovate the eye care industry. One of their groundbreaking developments is virtual eye exams, which are performed using commercially available VR headsets. These advanced exams allow eye care professionals to optimize their examination processes, ensure high standards of quality control, and gain valuable insights that aid in clinical decision-making. This successful funding round marks an exciting step forward in making eye care more efficient and accessible through technological advancements
